Biochemistry, Genetics and Molecular Biology
Protein
91%
Sample
52%
Peptide
52%
Development
44%
G Protein
39%
14-3-3 Protein
39%
Hybrid
39%
Polo-Like Kinase
39%
Primary Cell
39%
Phosphorylation
39%
Quantitative Proteomics
39%
Messenger RNA
39%
Nerve Cell Culture
39%
Detergent
39%
Membrane
34%
Tandem Mass Spectrometry
19%
Magnetic Resonance Imaging
17%
Clinical Trial
16%
Cell Membrane
13%
Regulatory Mechanism
13%
Protein Kinase C
13%
Crystal Structure
13%
Protein Kinase
13%
Coiled Coil
13%
C-Terminus
13%
Binding Site
13%
Rnd1
13%
Contrast
13%
Ras Superfamily
13%
Rho Factor
13%
Magnetic Resonance Imaging of Brain
13%
Time
11%
Proteomics
11%
Small Interfering RNA
11%
Gene Expression Profiling
11%
Radiation
9%
Protein Content
9%
Optics
9%
Digestion
9%
Sterol
9%
Volume
8%
Lysine
6%
Liquid Chromatography Mass Spectrometry
6%
Trypsin
6%
Nested Gene
5%
Small Molecule
5%
Keratinocyte
5%
Oncogene
5%
Aptitude
5%
Apoptosis
5%
Neuroscience
Protein
100%
Clinically Isolated Syndrome
78%
Alzheimer's Disease
78%
Multiple Sclerosis
78%
Brain Lesion
62%
Proteomics
44%
Peptide
39%
Primary Progressive Multiple Sclerosis
39%
Cyclin Dependent Kinase 5
39%
Neuron
39%
White Matter
39%
Gray Matter
39%
Magnetic Resonance Imaging
39%
Memory
39%
Synaptosome
39%
Gelsolin
39%
Magnetic Resonance Imaging
27%
Spinal Cord
19%
Magnetization Transfer
17%
Brain
17%
Predictor
15%
Expanded Disability Status Scale
14%
Neurodegeneration
13%
Optic Radiation
9%
Corpus Callosum
9%
Spatial Memory
8%
Optics
8%
Blood Proteins
8%
Western Blot
8%
Superior Longitudinal Fasciculus
7%
Trypsin
6%
Lysine
6%
Medicine and Dentistry
Multiple Sclerosis
78%
Magnetic Resonance Imaging
56%
Cells
44%
Cerebral Atrophy
43%
Inpatient
39%
Skin Carcinoma
39%
Messenger RNA
39%
Brain
39%
Clinically Isolated Syndrome
39%
Atopic Dermatitis
39%
Detergent
39%
Nerve Cell Culture
39%
Protein Analysis
39%
Membrane
34%
Atrophy
28%
Lesion
26%
Quality of Life
26%
Patient
25%
Cancer
16%
Parent
13%
Follow up
12%
Age
12%
In Vitro
11%
Small Interfering RNA
11%
Triton X 100
9%
Protein
9%
Randomized Controlled Trial
8%
Assessment
8%
Combination Therapy
8%
Measurement
7%
Marker
7%
Therapeutic Procedure
7%
Skin
7%
Disease Severity
6%
Cancer Therapy
5%
Tumour Heterogeneity
5%
Psoriasis
5%
Keratinocyte
5%
Programmed Cell Death
5%
Tumor Gene
5%
Aptitude
5%
Skin Tumor
5%
Tumor Progression
5%
Carcinogenesis
5%
Culture
5%
Gene
5%
Tumor Xenograft
5%